XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Accumulated Income
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2023   100.3        
Balance at beginning of period at Dec. 31, 2023 $ 2,255.2 $ 1.2 $ 1,787.0 $ 406.5 $ (547.2) $ 607.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 137.3     112.5   24.8
Receipt of treasury stock (shares)   (0.2)        
Receipt of treasury stock (12.1)       (12.1)  
Dividends declared (15.3)   0.1 (15.4)    
Stock-based compensation 9.3   9.3      
Distributions declared (30.5)         (30.5)
Capital contributions from consolidated affiliates 18.4         18.4
Other (shares)   0.6        
Other 0.0   0.8 0.1 (0.9)  
Balance at end of period (shares) at Mar. 31, 2024   100.7        
Balance at end of period at Mar. 31, 2024 2,362.3 $ 1.2 1,797.2 503.7 (560.2) 620.4
Balance at beginning of period (shares) at Dec. 31, 2024   100.8        
Balance at beginning of period at Dec. 31, 2024 2,792.7 $ 1.2 1,847.0 796.7 (577.9) 725.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 194.1     151.5   42.6
Issuance of restricted stock (in shares)   0.7        
Issuance of restricted stock 0.0   (27.7)   27.7  
Receipt of treasury stock (shares)   (0.2)        
Receipt of treasury stock (19.8)       (19.8)  
Dividends declared (17.4)     (17.4)    
Stock-based compensation 9.5   9.5      
Distributions declared (45.9)         (45.9)
Repurchases of common stock in open market (in shares)   (0.3)        
Repurchases of common stock in open market (32.1)       (32.1)  
Other (shares)   (0.1)        
Other 0.4   0.7   (0.3)  
Balance at end of period (shares) at Mar. 31, 2025   100.9        
Balance at end of period at Mar. 31, 2025 $ 2,881.5 $ 1.2 $ 1,829.5 $ 930.8 $ (602.4) $ 722.4